View Item 

Show simple item record

Efficient generation of CD34+ progenitorâ derived dendritic cells from Gâ CSFâ mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment
dc.contributor.authorPaczesny, Sophie
dc.contributor.authorLi, Yin‐ping
dc.contributor.authorLi, Na
dc.contributor.authorLatger‐cannard, Véronique
dc.contributor.authorMarchal, Luc
dc.contributor.authorOu‐yang, Jing‐ping
dc.contributor.authorBordigoni, Pierre
dc.contributor.authorStoltz, Jean‐françois
dc.contributor.authorEljaafari, Assia
dc.date.accessioned2018-02-05T16:37:59Z
dc.date.available2018-02-05T16:37:59Z
dc.date.issued2007-04
dc.identifier.citationPaczesny, Sophie; Li, Yin‐ping ; Li, Na; Latger‐cannard, Véronique ; Marchal, Luc; Ou‐yang, Jing‐ping ; Bordigoni, Pierre; Stoltz, Jean‐françois ; Eljaafari, Assia (2007). "Efficient generation of CD34+ progenitorâ derived dendritic cells from Gâ CSFâ mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment." Journal of Leukocyte Biology 81(4): 957-967.
dc.identifier.issn0741-5400
dc.identifier.issn1938-3673
dc.identifier.urihttps://hdl.handle.net/2027.42/141647
dc.publisherWiley Periodicals, Inc.
dc.subject.otherex vivo expansion
dc.subject.otherlipopolysaccharide
dc.subject.othercell vaccine
dc.subject.otherimmunotherapy
dc.titleEfficient generation of CD34+ progenitorâ derived dendritic cells from Gâ CSFâ mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Pediatrics, University of Michigan Cancer Center, Ann Arbor, Michigan, USA;
dc.contributor.affiliationotherHematology Department, Childrenâ s Hospital, CNRS UMR 7563, and Unit of Cellular and Tissue Therapy
dc.contributor.affiliationotherLaboratory of Hematology, CHU Nancy, France;
dc.contributor.affiliationotherImmunogenomics Mixed Unit, HCLâ BioMerieux, Lyon, France
dc.contributor.affiliationotherDepartment of Pathology and Pathophysiology, Wuhan University, Wuhan, China; and
dc.contributor.affiliationotherDepartment of Electron Microscopy, Faculty of Medicine, France and
dc.contributor.affiliationotherLaboratory of Mechanobiology and Engineering of Cells and Tissues, CNRS UMR 7563, and Unit of Cellular and Tissue Therapy, Faculty of Medicine, France
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141647/1/jlb0957.pdf
dc.identifier.doi10.1189/jlb.0406296
dc.identifier.sourceJournal of Leukocyte Biology
dc.identifier.citedreferenceMaraskovsky, E., Pulendran, B., Brasel, K., Teepe, M., Roux, E. R., Shortman, K., Lyman, S. D., McKenna, H. J. ( 1997 ) Dramatic numerical increase of functionally mature dendritic cells in FLT3 ligandâ treated mice. Adv. Exp. Med. Biol. 417, 33 â 40.
dc.identifier.citedreferenceSallusto, F., Lanzavecchia, A. ( 1994 ) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colonyâ stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109 â 1118.
dc.identifier.citedreferenceCaux, C., Dezutterâ Dambuyant, C., Schmitt, D., Banchereau, J. ( 1992 ) GMâ CSF and TNFâ α cooperate in the generation of dendritic Langerhans cells. Nature 360, 258 â 261.
dc.identifier.citedreferenceBanchereau, J., Steinman, R. M. ( 1998 ) Dendritic cells and the control of immunity. Nature 392, 245 â 252.
dc.identifier.citedreferenceCaux, C., Vanbervliet, B., Massacrier, C., Dubois, B., Dezutterâ Dambuyant, C., Schmitt, D., Banchereau, J. ( 1995 ) Characterization of human CD34+ derived dendritic/Langerhans cells (Dâ Lc). Adv. Exp. Med. Biol. 378, 1 â 5.
dc.identifier.citedreferenceWettendorff, M., Massacrier, C., Vanbervliet, B., Urbain, J., Banchereau, J., Caux, C. ( 1995 ) Activation of primary allogeneic CD8+ T cells by dendritic cells generated in vitro from CD34+ cord blood progenitor cells. Adv. Exp. Med. Biol. 378, 371 â 374.
dc.identifier.citedreferenceCaux, C., Massacrier, C., Dezutterâ Dambuyant, C., Vanbervliet, B., Jacquet, C., Schmitt, D., Banchereau, J. ( 1995 ) Human dendritic Langerhans cells generated in vitro from CD34+ progenitors can prime naive CD4+ T cells and process soluble antigen. J. Immunol. 155, 5427 â 5435.
dc.identifier.citedreferenceCaux, C., Vanbervliet, B., Massacrier, C., Dezutterâ Dambuyant, C., de Saintâ Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., Banchereau, J. ( 1996 ) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GMâ CSF+ TNF α. J. Exp. Med. 184, 695 â 706.
dc.identifier.citedreferenceCaux, C., Massacrier, C., Vanbervliet, B., Dubois, B., de Saintâ Vis, B., Dezutterâ Dambuyant, C., Jacquet, C., Schmitt, D., Banchereau, J. ( 1997 ) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GMâ CSF+ TNF α. Adv. Exp. Med. Biol. 417, 21 â 25.
dc.identifier.citedreferenceRomani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., Schuler, G. ( 1994 ) Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83 â 93.
dc.identifier.citedreferenceEljaafari, A., Duperrier, K., Mazet, S., Bardin, C., Bernaud, J., Durand, B., Gebuhrer, L., Betuel, H., Rigal, D. ( 1998 ) Generation of stable monocyteâ derived dendritic cells in the presence of high concentrations of homologous or autologous serum: influence of extraâ cellular pH. Hum. Immunol. 59, 625 â 634.
dc.identifier.citedreferenceDuperrier, K., Eljaafari, A., Dezutterâ Dambuyant, C., Bardin, C., Jacquet, C., Yoneda, K., Schmitt, D., Gebuhrer, L., Rigal, D. ( 2000 ) Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements. J. Immunol. Methods 238, 119 â 131.
dc.identifier.citedreferenceBanchereau, J., Palucka, A. K., Dhodapkar, M., Burkeholder, S., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K. M., Bhardwaj, N., Pineiro, L., Steinman, R., Fay, J. ( 2001 ) Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitorâ derived dendritic cell vaccine. Cancer Res. 61, 6451 â 6458.
dc.identifier.citedreferencePaczesny, S., Banchereau, J., Wittkowski, K. M., Saracino, G., Fay, J., Palucka, A. K. ( 2004 ) Expansion of melanomaâ specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitorâ derived dendritic cells. J. Exp. Med. 199, 1503 â 1511.
dc.identifier.citedreferencePaczesny, S., Shi, H., Saito, H., Mannoni, P., Fay, J., Banchereau, J., Palucka, A. K. ( 2005 ) Measuring melanomaâ specific cytotoxic T lymphocytes elicited by dendritic cell vaccines with a tumor inhibition assay in vitro. J. Immunother. 28, 148 â 157.
dc.identifier.citedreferenceLiu, A., Takahashi, M., Narita, M., Zheng, Z., Kanazawa, N., Abe, T., Nikkuni, K., Furukawa, T., Toba, K., Fuse, I., Aizawa, Y. ( 2002 ) Generation of functional and mature dendritic cells from cord blood and bone marrow CD34+ cells by twoâ step culture combined with calcium ionophore treatment. J. Immunol. Methods 261, 49 â 63.
dc.identifier.citedreferenceRyu, K. H., Cho, S. J., Jung, Y. J., Seoh, J. Y., Kie, J. H., Koh, S. H., Kang, H. J., Ahn, H. S., Shin, H. Y. ( 2004 ) In vitro generation of functional dendritic cells from human umbilical cord blood CD34+ cells by a 2â step culture method. Int. J. Hematol. 80, 281 â 286.
dc.identifier.citedreferenceDexter, T. M., Testa, N. G. ( 1976 ) Differentiation and proliferation of hemopoietic cells in culture. Methods Cell Biol. 14, 387 â 405.
dc.identifier.citedreferenceMuench, M. O., Schneider, J. G., Moore, M. A. ( 1992 ) Interactions among colonyâ stimulating factors, ILâ 1 β, ILâ 6, and kitâ ligand in the regulation of primitive murine hematopoietic cells. Exp. Hematol. 20, 339 â 349.
dc.identifier.citedreferenceMcKenna, H. J., Stocking, K. L., Miller, R. E., Brasel, K., De Smedt, T., Maraskovsky, E., Maliszewski, C. R., Lynch, D. H., Smith, J., Pulendran, B., Roux, E. R., Teepe, M., Lyman, S. D., Peschon, J. J. ( 2000 ) Mice lacking Flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95, 3489 â 3497.
dc.identifier.citedreferencePulendran, B., Banchereau, J., Burkeholder, S., Kraus, E., Guinet, E., Chalouni, C., Caron, D., Maliszewski, C., Davoust, J., Fay, J., Palucka, K. ( 2000 ) Flt3â ligand and granulocyte colonyâ stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165, 566 â 572.
dc.identifier.citedreferenceSaraya, K., Reid, C. D. ( 1996 ) Stem cell factor and the regulation of dendritic cell production from CD34+ progenitors in bone marrow and cord blood. Br. J. Haematol. 93, 258 â 264.
dc.identifier.citedreferenceSiena, S., Di Nicola, M., Bregni, M., Mortarini, R., Anichini, A., Lombardi, L., Ravagnani, F., Parmiani, G., Gianni, A. M. ( 1995 ) Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. Exp. Hematol. 23, 1463 â 1471.
dc.identifier.citedreferenceRosenzwajg, M., Camus, S., Guigon, M., Gluckman, J. C. ( 1998 ) The influence of interleukin (IL)â 4, ILâ 13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells. Exp. Hematol. 26, 63 â 72.
dc.identifier.citedreferenceRosenzwajg, M., Canque, B., Gluckman, J. C. ( 1996 ) Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood 87, 535 â 544.
dc.identifier.citedreferenceLardon, F., Snoeck, H. W., Berneman, Z. N., Van Tendeloo, V. F., Nijs, G., Lenjou, M., Henckaerts, E., Boeckxtaens, C. J., Vandenabeele, P., Kestens, L. L., Van Bockstaele, D. R., Vanham, G. L. ( 1997 ) Generation of dendritic cells from bone marrow progenitors using GMâ CSF, TNFâ α, and additional cytokines: antagonistic effects of ILâ 4 and IFNâ γ and selective involvement of TNFâ α receptorâ 1. Immunology 91, 553 â 559.
dc.identifier.citedreferenceVan Duin, D., Medzhitov, R., Shaw, A. C. ( 2006 ) Triggering TLR signaling in vaccination. Trends Immunol. 27, 49 â 55.
dc.identifier.citedreferenceGatti, E., Velleca, M. A., Biedermann, B. C., Ma, W., Unternaehrer, J., Ebersold, M. W., Medzhitov, R., Pober, J. S., Mellman, I. ( 2000 ) Largescale culture and selective maturation of human Langerhans cells from granulocyte colonyâ stimulating factorâ mobilized CD34+ progenitors. J. Immunol. 164, 3600 â 3607.
dc.identifier.citedreferenceMacAry, P. A., Lindsay, M., Scott, M. A., Craig, J. I., Luzio, J. P., Lehner, P. J. ( 2001 ) Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34â derived human Langerhans cells. Proc. Natl. Acad. Sci. USA 98, 3982 â 3987.
dc.identifier.citedreferenceChen, Z., Dehm, S., Bonham, K., Kamencic, H., Juurlink, B., Zhang, X., Gordon, J. R., Xiang, J. ( 2001 ) DNA array and biological characterization of the impact of the maturation status of mouse dendritic cells on their phenotype and antitumor vaccination efficacy. Cell. Immunol. 214, 60 â 71.
dc.identifier.citedreferenceBlander, J. M., Medzhitov, R. ( 2006 ) Tollâ dependent selection of microbial antigens for presentation by dendritic cells. Nature 440, 808 â 812.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jlb0957.pdf
Size:
658.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.